Author

Aikou Okamoto

Jikei University School of MedicineORCID 0000-0002-5079-0464Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Ayako KawabataiD· 1 shared C. Simon HerringtoniD· 1 shared Charlie GourleyiD· 1 shared Clare Bartos· 1 shared Daniel MarksiD· 1 shared Darren P. EnnisiD· 1 shared Gaia GiannoneiD· 1 shared Giorgio ValabregaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Ayako KawabataORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial transcriptomic analysis reveals coordinated gene expression in ovarian clear cell carcinoma and adjacent endometriosis in UK and Japanese patients

Takafumi Kuroda, Gaia Giannone, Darren P. Ennis, Hasan Mirza, Daniel Marks, Louis Flood, Mary Sisley, Ryan Griffin, S. Desai, Jacqueline R. McDermott, Nathalie Lambie, Nei Fukasawa, Takako Kiyokawa, Masayuki Shimoda, Misato Saito, , Iain A. McNeish

This study uses spatial transcriptomics to compare gene expression in ovarian clear cell carcinoma and adjacent endometriosis across UK and Japanese patients, finding distinct transcriptional patterns by tissue compartment rather than geographic origin.

bioRxiv · Jun 2, 2026 · PreprintPathology

Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma

Yasushi Iida, Michael Churchman, Robert L. Hollis, Sarah Elizabeth Taylor, Clare Bartos, Ian Croy, William Gentleman, Tzyvia Rye, Rachel Nirsimloo, C. Simon Herrington, Charlie Gourley, Aikou Okamoto, John P. Thomson

This study identifies ARID1A mutation and low CD3+ TIL levels as prognostic markers for relapse in low-stage clear cell ovarian carcinoma.

Gynecologic Oncology · May 27, 2025Peer-reviewedCancer Biology